Royal Bank of Canada’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-852
| Closed | – | – | 7076 |
|
|
2025
Q4 | $0 | Sell |
852
-201,960
| -100% | -$128K | ﹤0.01% | 7138 |
|
|
2025
Q3 | $122K | Buy |
202,812
+201,490
| +15,241% | +$94.9K | ﹤0.01% | 5400 |
|
|
2025
Q2 | $0 | Sell |
1,322
-1,626
| -55% | -$629 | ﹤0.01% | 7002 |
|
|
2025
Q1 | $1K | Sell |
2,948
-3,738
| -56% | -$2.2K | ﹤0.01% | 6622 |
|
|
2024
Q4 | $6K | Sell |
6,686
-28,670
| -81% | -$180K | ﹤0.01% | 6472 |
|
|
2024
Q3 | $301K | Sell |
35,356
-2,687
| -7% | -$15.8K | ﹤0.01% | 4500 |
|
|
2024
Q2 | $177K | Buy |
+38,043
| New | +$180K | ﹤0.01% | 4861 |
|
|
2024
Q1 | – | Sell |
-2,141
| Closed | -$7K | – | 6978 |
|
|
2023
Q4 | $7K | Buy |
2,141
+2,059
| +2,511% | +$5.12K | ﹤0.01% | 6574 |
|
|
2023
Q3 | $0 | Buy |
+82
| New | +$135 | ﹤0.01% | 7048 |
|
|
2022
Q4 | – | Sell |
-58
| Closed | – | – | 7187 |
|
|
2022
Q3 | $0 | Buy |
+58
| New | +$70 | ﹤0.01% | 7412 |
|
|
2022
Q2 | – | Sell |
-1,089
| Closed | -$2K | – | 7339 |
|
|
2022
Q1 | $2K | Sell |
1,089
-3,288
| -75% | -$8.81K | ﹤0.01% | 7453 |
|
|
2021
Q4 | $39K | Buy |
4,377
+2,226
| +103% | +$29.2K | ﹤0.01% | 6508 |
|
|
2021
Q3 | $36K | Buy |
2,151
+938
| +77% | +$16.2K | ﹤0.01% | 6345 |
|
|
2021
Q2 | $25K | Sell |
1,213
-493
| -29% | -$9.33K | ﹤0.01% | 6440 |
|
|
2021
Q1 | $32K | Buy |
1,706
+1,367
| +403% | +$29.5K | ﹤0.01% | 6155 |
|
|
2020
Q4 | $7K | Buy |
339
+323
| +2,019% | +$6.72K | ﹤0.01% | 6515 |
|
|
2020
Q3 | $0 | Sell |
16
-4
| -20% | -$104 | ﹤0.01% | 6587 |
|
|
2020
Q2 | $1K | Sell |
20
-23
| -53% | -$963 | ﹤0.01% | 6375 |
|
|
2020
Q1 | $1K | Sell |
43
-276
| -87% | -$11.2K | ﹤0.01% | 6393 |
|
|
2019
Q4 | $9K | Buy |
319
+222
| +229% | +$3.8K | ﹤0.01% | 6169 |
|
|
2019
Q3 | $1K | Buy |
+97
| New | +$915 | ﹤0.01% | 6393 |
|
Royal Bank of Canada's APLT Position: Q1 2026 in Review
Royal Bank of Canada sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 852 shares.
Royal Bank of Canada first reported a position in APLT in Q3 2019 and held it in 21 quarters. The position peaked at $301K in Q3 2024. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Royal Bank of Canada reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Royal Bank of Canada sold 852 Applied Therapeutics shares in Q1 2026.
- Royal Bank of Canada first reported a position in Applied Therapeutics in Q3 2019 and held it in 21 quarters.
- Royal Bank of Canada's Applied Therapeutics position peaked at $301K in Q3 2024.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.